| Blogger Talks to Novocell About First CIRM Loan October 29, 2009 at 4:03 pm |
| Little information was dispensed yesterday by the California stem cell agency about the first step in what is proposed to be a $500 million loan program for the biotech industry.But a biopharmaceutical industry blogger provided some information about the $20 million loan to Novocell, Inc., a San Diego stem cell engineering company with an emphasis on diabetes therapies. It is the first |
| Disease Team News Coverage, Irony and a 'Sinking' State October 29, 2009 at 12:49 pm |
| The California stem cell agency's $230 million disease team research effort, which boosted CIRM's spending beyond $1 billion, attracted moderate news coverage this morning and late yesterday.Some publications, however, appeared to ignore the story entirely, including the Los Angeles Times and The Sacramento Bee, based on our Internet searches. The performance of the Times was particularly strange |
| NY Times: CIRM Moves Away From hESC October 29, 2009 at 12:45 am |
| The New York Times today reported that the California stem cell agency has made a "tacit acknowledgment that the promise of human embryonic stem cells is still far in the future."Reporter Andrew Pollack wrote that only 4 of the 14 disease team projects approved by CIRM today involve embryonic stem cells. He said,"The others will use so-called adult stem cells or conventional drugs intended to | |
|
No comments:
Post a Comment